Combination therapy with belimumab and low‐dose interleukin‐2 in a patient with anti‐MDA5 antibody dermatomyositis overlapping with systemic lupus erythematosus.

Saved in:
Bibliographic Details
Title: Combination therapy with belimumab and low‐dose interleukin‐2 in a patient with anti‐MDA5 antibody dermatomyositis overlapping with systemic lupus erythematosus.
Authors: Feng, Ruiling1 (AUTHOR), Zhang, Xia1 (AUTHOR), He, Jing1 (AUTHOR) hejing@pkuph.edu.cn
Source: Rheumatology & Autoimmunity. Mar2025, Vol. 5 Issue 1, p73-74. 2p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:27671429
DOI:10.1002/rai2.12154